Isabelle K. Vila, et.al., A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy., Cancer cell, 2017, 31

http://rdf.ncbi.nlm.nih.gov/pubmed/28162974

Isabelle K. Vila, et.al., A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy., Cancer cell, 2017, 31

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased B cell derived lymphoma incidence_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BLC57BL6NFVBNSJLUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgIghMyc22Bri0TgIghMyc22BriUbe2otm11KOMPMbp
• increased tumor latency_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0009828IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgMMTVPyVT634Mul0Ube2otm11KOMPMbpTgMMTVPyVT634Mul
• mammary gland hypoplasia_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0003344IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgMMTVPyVT634Mul0Ube2otm11KOMPMbpTgMMTVPyVT634Mul
• decreased survivor rate_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0008770IC57BLC57BL6NFVBNSJLUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgIghMyc22Bri0TgIghMyc22BriUbe2otm11KOMPMbp
• abnormal survival_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0010769IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgMMTVPyVT634Mul0Ube2otm11KOMPMbpTgMMTVPyVT634Mul
• decreased tumor growth/size_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0003447IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgMMTVPyVT634Mul0Ube2otm11KOMPMbpTgMMTVPyVT634Mul
• decreased tumor growth/size_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<+>,Tg(TRAMP)8247Ng/0
  http://metadb.riken.jp/0003447IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2oTgTRAMP8247Ng0Ube2otm11KOMPMbpTgTRAMP8247NgUbe2o
• abnormal survival_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<+>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0010769IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul0Ube2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul
• increased lymphoma incidence_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Pten<tm1Ppp>/Pten<tm1Ppp>
  http://metadb.riken.jp/0012431I129S1SvC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpPtentm1PppPtentm1PppUbe2otm11KOMPMbpPtentm1Ppp
• decreased metastatic potential_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(TRAMP)8247Ng/0
  http://metadb.riken.jp/0001273IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgTRAMP8247Ng0Ube2otm11KOMPMbpTgTRAMP8247Ng
• abnormal cell physiology_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>
  http://metadb.riken.jp/0005621IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpUbe2otm11KOMPMbp
• decreased tumor growth/size_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<+>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0003447IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul0Ube2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul
• decreased tumor growth/size_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>,Tg(TRAMP)8247Ng/0
  http://metadb.riken.jp/0003447IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpTgTRAMP8247Ng0Ube2otm11KOMPMbpTgTRAMP8247Ng
• abnormal cell migration_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>
  http://metadb.riken.jp/0003091IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpUbe2otm11KOMPMbp
• increased tumor latency_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<+>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0009828IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul0Ube2otm11KOMPMbpUbe2oTgMMTVPyVT634Mul
• decreased fibroblast proliferation_Ube2o<tm1.1(KOMP)Mbp>/Ube2o<tm1.1(KOMP)Mbp>
  http://metadb.riken.jp/0011704IC57BL6C57BL6NFVBNUbe2otm11KOMPMbpUbe2otm11KOMPMbpUbe2otm11KOMPMbp